Title |
Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples
|
---|---|
Published in |
Drug Safety, December 2012
|
DOI | 10.2165/11594770-000000000-00000 |
Pubmed ID | |
Authors |
Peter M. Wahl, Joshua J. Gagne, Thomas E. Wasser, Debra F. Eisenberg, J. Keith Rodgers, Gregory W. Daniel, Marcus Wilson, Sebastian Schneeweiss, Jeremy A. Rassen, Amanda R. Patrick, Jerry Avorn, Rhonda L. Bohn |
Abstract |
Several efforts are under way to develop and test methods for prospective drug safety monitoring using large, electronic claims databases. Prospective monitoring systems must incorporate signalling algorithms and techniques to mitigate confounding in order to minimize false positive and false negative signals due to chance and bias. |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 3% |
Korea, Republic of | 1 | 3% |
Finland | 1 | 3% |
Canada | 1 | 3% |
United States | 1 | 3% |
Unknown | 34 | 87% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 21% |
Student > Ph. D. Student | 5 | 13% |
Student > Doctoral Student | 4 | 10% |
Researcher | 3 | 8% |
Other | 3 | 8% |
Other | 8 | 21% |
Unknown | 8 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 54% |
Psychology | 2 | 5% |
Nursing and Health Professions | 2 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Other | 1 | 3% |
Unknown | 11 | 28% |